A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

King Faisal Specialist Hospital & Research Center

Status: Completed

Conditions: Colon Rectal Cancer Duke Stage Stageval

Treatments: Drug: Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®)

Study type: Observational

Funder types: Other

Identifiers

NCT01310985

RAC# 2071-051 (Other Identifier)

Details and patient eligibility

About

A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer

Full description

Its a pilot study of pre-op chemotherapy and RT utilizing CAPECITABINE, XRT and CETUXIMAB in pts with locally advanced rectal carcinoma.

Enrollment: 15 patients

Sex: All

Ages: 14 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Localized Non-Metastatic Rectal Cancer

Exclusion criteria

• Patients with diagnosis other than Localized Non-Metastatic Rectal Cancer